I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| adipocyte | 7 studies | 30% ± 10% | |
| epithelial cell | 6 studies | 36% ± 15% | |
| hematopoietic precursor cell | 5 studies | 26% ± 7% | |
| naive B cell | 5 studies | 16% ± 1% | |
| classical monocyte | 4 studies | 23% ± 6% | |
| endothelial cell | 4 studies | 23% ± 3% | |
| precursor B cell | 4 studies | 20% ± 2% | |
| myeloid cell | 4 studies | 26% ± 3% | |
| dendritic cell | 4 studies | 32% ± 13% | |
| conventional dendritic cell | 3 studies | 45% ± 8% | |
| non-classical monocyte | 3 studies | 25% ± 7% | |
| basal cell | 3 studies | 21% ± 3% | |
| pro-B cell | 3 studies | 30% ± 13% | |
| retinal cone cell | 3 studies | 23% ± 5% | |
| GABAergic neuron | 3 studies | 36% ± 1% | |
| astrocyte | 3 studies | 26% ± 3% | |
| glutamatergic neuron | 3 studies | 43% ± 5% | |
| transit amplifying cell | 3 studies | 26% ± 3% | |
| plasmacytoid dendritic cell | 3 studies | 22% ± 3% | |
| erythroblast | 3 studies | 33% ± 13% | |
| natural killer cell | 3 studies | 19% ± 5% | |
| CD4-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
| regulatory T cell | 3 studies | 17% ± 1% |
